AbstractThe free fatty acid receptor 1 (FFAR1) is a class A G-protein coupled receptor and a validated target to develop antidiabetic drugs. The present work describes the quantitative structure–activity relationship (QSAR) study of a series of 4-alkynyldihydrocinnamic acid analogs to rationalize their FFAR1 agonist activity. The various physicochemical and structural descriptors were derived from Molecular Operating Environment (MOE, 2011). The variable selection and model development were carried out using Combinatorial Protocol in Multiple Linear Regressions (CP-MLR) approach. The identified QSAR models highlighted the significance of solvent accessible surface area and associated hydrophobicity to the biological activity. The chemical f...
The free fatty acid receptor 1 (FFA1 or GPR40) is established as an interesting potential target for...
The paradigm of ligand-receptor interactions postulated as “one compound—one target” has been evolvi...
The free fatty acid receptor 1 (FFA1, also known as GPR40) mediates enhancement of glucosestimulate...
AbstractThe free fatty acid receptor 1 (FFAR1) is a class A G-protein coupled receptor and a validat...
Free fatty acid receptor 1 (FFA1) stimulates insulin secretion in pancreatic β-cells. An advantage o...
 Background: The identification of potential compounds for an anti-hyperglycemic makes real challen...
Type 2 diabetes is becoming a global pandemic disease. As an important target for the generation and...
Farnesoid X receptor (FXR) is a nuclear receptor related to lipid and glucose homeostasis and is con...
The peroxisome proliferator-activated receptors (PPARs) have increasingly become attractive targets ...
32-36Quantitative structure-activity relationship (QSAR) has been established on a series of thirty-...
The free fatty acid receptors (FFA) 1 (previously designated GPR40) and FFA4 (previously GPR120) are...
The long-chain fatty acid receptor FFA4(previously GPR120) is receiving substantial interest as a no...
The progress made so far in the elucidation of the structure of free fatty acid receptor 1 (FFAR1) a...
A set of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors was investigated with th...
Free fatty acid receptor 3 (FFA3, previously GPR41) is activated by short-chain fatty acids, mediate...
The free fatty acid receptor 1 (FFA1 or GPR40) is established as an interesting potential target for...
The paradigm of ligand-receptor interactions postulated as “one compound—one target” has been evolvi...
The free fatty acid receptor 1 (FFA1, also known as GPR40) mediates enhancement of glucosestimulate...
AbstractThe free fatty acid receptor 1 (FFAR1) is a class A G-protein coupled receptor and a validat...
Free fatty acid receptor 1 (FFA1) stimulates insulin secretion in pancreatic β-cells. An advantage o...
 Background: The identification of potential compounds for an anti-hyperglycemic makes real challen...
Type 2 diabetes is becoming a global pandemic disease. As an important target for the generation and...
Farnesoid X receptor (FXR) is a nuclear receptor related to lipid and glucose homeostasis and is con...
The peroxisome proliferator-activated receptors (PPARs) have increasingly become attractive targets ...
32-36Quantitative structure-activity relationship (QSAR) has been established on a series of thirty-...
The free fatty acid receptors (FFA) 1 (previously designated GPR40) and FFA4 (previously GPR120) are...
The long-chain fatty acid receptor FFA4(previously GPR120) is receiving substantial interest as a no...
The progress made so far in the elucidation of the structure of free fatty acid receptor 1 (FFAR1) a...
A set of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors was investigated with th...
Free fatty acid receptor 3 (FFA3, previously GPR41) is activated by short-chain fatty acids, mediate...
The free fatty acid receptor 1 (FFA1 or GPR40) is established as an interesting potential target for...
The paradigm of ligand-receptor interactions postulated as “one compound—one target” has been evolvi...
The free fatty acid receptor 1 (FFA1, also known as GPR40) mediates enhancement of glucosestimulate...